Inventor
CHAKKA NAGASREE
CA30 patents
⚠️ This page may combine multiple inventors who share the name “CHAKKA NAGASREE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENON PHARMACEUTICALS INC
14 patentsUS7335658B2Feb 26, 2008
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC59 citations97
US7767677B2Aug 3, 2010
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC34 citations92
US7700641B2Apr 20, 2010
Spiro-oxindole compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC39 citations92
US7592343B2Sep 22, 2009
Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC22 citations92
US7547698B2Jun 16, 2009
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
XENON PHARMACEUTICALS INC18 citations84
US8916580B2Dec 23, 2014
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC4 citations83
US7919484B2Apr 5, 2011
Combination therapy
XENON PHARMACEUTICALS INC10 citations83
US7763618B2Jul 27, 2010
Pyridyl derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC2 citations62
US7754711B2Jul 13, 2010
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC2 citations62
US9458178B2Oct 4, 2016
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC1 citations61
US8026360B2Sep 27, 2011
Substituted pyridazines as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC3 citations61
US7919496B2Apr 5, 2011
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
XENON PHARMACEUTICALS INC1 citations52
US8383628B2Feb 26, 2013
Pyridyl derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC0 citations51
US7951805B2May 31, 2011
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
XENON PHARMACEUTICALS INC0 citations41
AMGEN INC
6 patentsUS9663508B2May 30, 2017
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
AMGEN INC29 citations93
US9505749B2Nov 29, 2016
Quinazolinone compounds and derivatives thereof
AMGEN INC3 citations72
US9012443B2Apr 21, 2015
Bicyclic aryl and heteroaryl sodium channel inhibitors
AMGEN INC6 citations70
US9340549B2May 17, 2016
Oxazolidinone compounds and derivatives thereof
AMGEN INC1 citations51
US9365522B2Jun 14, 2016
Pyrazole amide derivative
AMGEN INC2 citations47
US9346798B2May 24, 2016
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
AMGEN INC0 citations38
CHAFEEV MIKHAIL
4 patentsUS8466188B2Jun 18, 2013
Use of spiro-oxindole compounds as therapeutic agents
CHAFEEV MIKHAIL63 citations97
US8106087B2Jan 31, 2012
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL19 citations92
US8263606B2Sep 11, 2012
Spiro-oxindole compounds and their use as therapeutic agents
CHAFEEV MIKHAIL16 citations91
US8415370B2Apr 9, 2013
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL10 citations82